This study was presented in a poster session at the 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 26 August 2012 in Barcelona, Spain.
Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension: the case of benzodiazepines†
Article first published online: 3 JUN 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 22, Issue 9, pages 933–941, September 2013
How to Cite
Bijlsma, M. J., Hak, E., Bos, J., De Jong-van den Berg, L. T. W. and Janssen, F. (2013), Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension: the case of benzodiazepines. Pharmacoepidem. Drug Safe., 22: 933–941. doi: 10.1002/pds.3466
- Issue published online: 20 AUG 2013
- Article first published online: 3 JUN 2013
- Manuscript Accepted: 29 APR 2013
- Manuscript Revised: 11 FEB 2013
- Manuscript Received: 3 SEP 2012
Additional supporting information may be found in the online version of this article:
|pds_3466_sm_figures.docx||Word 2007 document||858K||Supporting Information|
|pds_3466_sm_table.docx||Word 2007 document||15K||Supporting Information|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.